75A50124C00010↗
Kaleo, Inc. received this contract from Barda - Aspr / Daappo / Barda Dcma, Office of Assistant Secretary for Preparedness and Response: $33.26M obligated so far for health r&d services; health care - other; applied research. It runs to 2028-10-31.
Key facts · data as of Oct 25, 2026
- Recipient
- Kaleo, Inc.
- Awarding agency
- Office of Assistant Secretary for Preparedness and Response (Department of Health and Human Services)
- Contracting office
- Barda - Aspr / Daappo / Barda Dcma (75A501)
- Obligated to date
- $33.26M
- Potential value
- $33.76M
- Ends
- 2028-10-31
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75A50124C00010, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75A50124C00010_7505_-NONE-_-NONE-
Kaleo, Inc.: all federal awards · Department of Health and Human Services: spending · Barda - Aspr / Daappo / Barda Dcma: what it buys
DEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE
What it is
- Product or service
- Health R&D Services; Health Care - Other; Applied Research (PSC AN42)
- Industry
- Research and Development in Biotechnology (Except Nanobiotechnology) (NAICS 541714)
- Contracting office
- Barda - Aspr / Daappo / Barda Dcma (75A501)
- Competition
- Full and open competition · 1 offer received
- Pricing
- Cost plus fixed fee
- How it was bought
- Standalone contract
- Solicitation
- BAA-23-100-SOL-00004
- Where the work is
- Richmond (City), VA · district VA-04
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
4 actions since 2024-04-11. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-03-16 | P00003 | Option exercised | $3.78M | DEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE |
| 2024-12-20 | P00002 | Option exercised | $26.00M | DEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE |
| 2024-09-05 | P00001 | Supplemental agreement (work within scope) | $0 | DEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE |
| 2024-04-11 | 0 | $3.48M | DEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗